Frontiers in Endocrinology (Oct 2023)
Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus
- M. Guftar Shaikh,
- Angela K. Lucas-Herald,
- Antonia Dastamani,
- Maria Salomon Estebanez,
- Senthil Senniappan,
- Noina Abid,
- Sumera Ahmad,
- Sophie Alexander,
- Bindu Avatapalle,
- Neelam Awan,
- Hester Blair,
- Roisin Boyle,
- Alexander Chesover,
- Barbara Cochrane,
- Ross Craigie,
- Annaruby Cunjamalay,
- Sarah Dearman,
- Paolo De Coppi,
- Paolo De Coppi,
- Karen Erlandson-Parry,
- Sarah E. Flanagan,
- Clare Gilbert,
- Niamh Gilligan,
- Caroline Hall,
- Jayne Houghton,
- Ritika Kapoor,
- Helen McDevitt,
- Zainab Mohamed,
- Kate Morgan,
- Jacqueline Nicholson,
- Ana Nikiforovski,
- Elaine O'Shea,
- Pratik Shah,
- Kirsty Wilson,
- Chris Worth,
- Sarah Worthington,
- Indraneel Banerjee
Affiliations
- M. Guftar Shaikh
- Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, United Kingdom
- Angela K. Lucas-Herald
- Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, United Kingdom
- Antonia Dastamani
- Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- Maria Salomon Estebanez
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Senthil Senniappan
- Department of Paediatric Endocrinology, Alder Hey Children’s Hospital, Liverpool, United Kingdom
- Noina Abid
- Department of Paediatric Endocrinology, Royal Belfast Hospital for Sick Children, Belfast, United Kingdom
- Sumera Ahmad
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Sophie Alexander
- Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- Bindu Avatapalle
- Department of Paediatric Endocrinology and Diabetes, University Hospital of Wales, Cardiff, United Kingdom
- Neelam Awan
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Hester Blair
- Department of Dietetics, The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
- Roisin Boyle
- Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, United Kingdom
- Alexander Chesover
- Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- Barbara Cochrane
- Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, United Kingdom
- Ross Craigie
- Department of Paediatric Surgery, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Annaruby Cunjamalay
- Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- Sarah Dearman
- The Children’s Hyperinsulinism Charity, Accrington, United Kingdom
- Paolo De Coppi
- 0SNAPS, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- Paolo De Coppi
- 1NIHR BRC UCL Institute of Child Health, London, United Kingdom
- Karen Erlandson-Parry
- Department of Paediatric Endocrinology, Alder Hey Children’s Hospital, Liverpool, United Kingdom
- Sarah E. Flanagan
- 2Department of Clinical and Biomedical Science, University of Exeter, Exeter, United Kingdom
- Clare Gilbert
- Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- Niamh Gilligan
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Caroline Hall
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Jayne Houghton
- 3Exeter Genomics Laboratory, Royal Devon University Healthcare NHS Foundation Trust, Exeter, United Kingdom
- Ritika Kapoor
- 4Department of Paediatric Endocrinology, Faculty of Medicine and Life Sciences, King’s College London, King’s College Hospital NHS Foundation Trust, London, United Kingdom
- Helen McDevitt
- Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, United Kingdom
- Zainab Mohamed
- 5Department of Paediatric Endocrinology, Birmingham Children's Hospital, Birmingham, United Kingdom
- Kate Morgan
- Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
- Jacqueline Nicholson
- 6Paediatric Psychosocial Service, Royal Manchester Children’s Hospital, Manchester, United Kingdom
- Ana Nikiforovski
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Elaine O'Shea
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Pratik Shah
- 7Department of Paediatric Endocrinology, Barts Health NHS Trust, Royal London Children’s Hospital, London, United Kingdom
- Kirsty Wilson
- Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, United Kingdom
- Chris Worth
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Sarah Worthington
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- Indraneel Banerjee
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom
- DOI
- https://doi.org/10.3389/fendo.2023.1231043
- Journal volume & issue
-
Vol. 14
Abstract
Congenital hyperinsulinism (CHI) is a condition characterised by severe and recurrent hypoglycaemia in infants and young children caused by inappropriate insulin over-secretion. CHI is of heterogeneous aetiology with a significant genetic component and is often unresponsive to standard medical therapy options. The treatment of CHI can be multifaceted and complex, requiring multidisciplinary input. It is important to manage hypoglycaemia in CHI promptly as the risk of long-term neurodisability arising from neuroglycopaenia is high. The UK CHI consensus on the practice and management of CHI was developed to optimise and harmonise clinical management of patients in centres specialising in CHI as well as in non-specialist centres engaged in collaborative, networked models of care. Using current best practice and a consensus approach, it provides guidance and practical advice in the domains of diagnosis, clinical assessment and treatment to mitigate hypoglycaemia risk and improve long term outcomes for health and well-being.
Keywords
- congenital hyperinsulinism
- glucose
- hypoglycaemia
- consensus
- patient organisation
- standardised practice